These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10051823)

  • 41. Bladder dysfunction in children.
    Cisternino A; Passerini-Glazel G
    Scand J Urol Nephrol Suppl; 1995; 173():25-8; discussion 29. PubMed ID: 8719562
    [No Abstract]   [Full Text] [Related]  

  • 42. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity.
    Vermandel A; de Wachter S; Wyndaele JJ
    BJU Int; 2005 Sep; 96(4):629-33. PubMed ID: 16104923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis.
    Varan B; Saatçi U; Ozen S; Bakkaloğlu A; Beşbaş N
    Turk J Pediatr; 1996; 38(2):155-9. PubMed ID: 8701478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelized analysis of pressure-flow studies of patients with lower urinary tract symptoms due to benign prostatic enlargement.
    Valentini FA; Zimmern PE; Besson GR; Nelson PP
    Neurourol Urodyn; 2003; 22(1):45-53. PubMed ID: 12478601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary nocturnal enuresis persistent to adulthood, functional evaluation.
    Wadie BS
    Neurourol Urodyn; 2004; 23(1):54-7. PubMed ID: 14694458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug therapy in urinary incontinence and/or bladder emptying problems].
    Møller LA; Abel I; Thyssen H; Sander P; Mouritsen L; Lose G; Sørensen C; Philipsen J; Ottesen M; Rasmussen FA; Topp M; Larsen J; Gimbel H
    Ugeskr Laeger; 2006 Jun; 168(26-32):2580-1; author reply 2581. PubMed ID: 16824423
    [No Abstract]   [Full Text] [Related]  

  • 49. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K; Masuda M; Noguchi S; Kubota Y; Hosaka M; Senga Y; Sano K; Miyai K; Kanno H; Kitami K; Fujinami K; Miura T; Kondo I; Kawasaki C; Moriyama M; Hara Y; Ida T; Fukuoka H; Nakagawa J; Kitajima N; Fukuda M; Satomi Y; Takahashi T; Yamaguchi T; Shiozaki H
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anticholinergic treatment of overactive bladder. A costly treatment with doubtful clinical effect?].
    Møller LA; Lose G
    Ugeskr Laeger; 2003 Nov; 165(47):4552-3. PubMed ID: 14677238
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis.
    Ferrara P; Marrone G; Mastrangelo A; Nicoletti A; Emmanuele V; Fasano A
    Scand J Urol Nephrol; 2007; 41(3):218-22. PubMed ID: 17469031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR; Te AE
    BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of salivary stimulant pastilles to improve compliance in women taking oxybutinin hydrochloride for detrusor instability.
    Arango O
    Br J Urol; 1998 Apr; 81(4):652. PubMed ID: 9598656
    [No Abstract]   [Full Text] [Related]  

  • 54. [Unstable bladder in childhood].
    Rodríguez E; Holzer J; Triviño X; Alvarez J; Saieh C; Puga F
    Rev Chil Pediatr; 1985; 56(1):45-8. PubMed ID: 4081179
    [No Abstract]   [Full Text] [Related]  

  • 55. Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele.
    Kessler TM; Lackner J; Kiss G; Rehder P; Madersbacher H
    Neurourol Urodyn; 2006; 25(4):361-7. PubMed ID: 16721816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and management of dysfunctional voiding.
    Feldman AS; Bauer SB
    Curr Opin Pediatr; 2006 Apr; 18(2):139-47. PubMed ID: 16601493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatments of urination disorders in children (vesico-sphincteral disorders other than enuresis)].
    De Dreuzy P; Lenoir G
    Rev Prat; 1991 Nov; 41(23):2306-10. PubMed ID: 1792492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ambulatory monitoring of urodynamics in the diagnosis of urination disorders in women].
    Loran OB; Bernikov AN; Godunov BN; Pushkar' DIu
    Urol Nefrol (Mosk); 1998; (4):51-6. PubMed ID: 9727327
    [No Abstract]   [Full Text] [Related]  

  • 59. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
    Giannitsas K; Perimenis P; Athanasopoulos A; Gyftopoulos K; Nikiforidis G; Barbalias G
    Eur Urol; 2004 Dec; 46(6):776-82; discussion 782-3. PubMed ID: 15548447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.